CompletedNCT01986296
ExAblate Focused Ultrasound for Treatment-Resistant OCD
About this title
ExAblate Treatment of Medication Refractory Obsessive Compulsive Disorder
Read the official source — NCT01986296Device studyAges 18–65South Korea
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- SeoulSee all locations and recruitment
Study information
Study start dateJanuary 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- InSightec
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Locations
- South Korea
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01986296
- Official title
Show the full official title
A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound Treatment of Medication-Refractory OCD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Seoul
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is InSightec.
Who was this study for?
Listed age limits: 18 years to 65 years.
